Delivery Order SPE2DB24D1021-SPE2DB25FEYMM
- Not listed
- The Defense Logistics Agency awarded a $2,360.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on July 25, 2025, with a completion date of July 28, 2025. This non-competitive delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the Department of Defense medical supply chain. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,904.63 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens on July 28, 2025, with completion expected by July 29, 2025. This firm fixed-price delivery order, executed without set-aside designation, represents a competitive award to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The product will be delivered to the same location, supporting the federal government's medical...
- The Defense Logistics Agency awarded a $1,360.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This contract was awarded competitively with no set-aside designation and has an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under a larger procurement vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $1,904.63 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pens on June 2, 2025, with completion scheduled for June 3, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded pharmaceutical procurement supporting military and federal healthcare needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $54,083.66 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on September 12, 2025. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by September 15, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $7,979.98 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens. This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, issued under a non-competitive, non-set-aside procurement. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens valued at $8,354.94, with an ultimate completion date of September 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement within the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $2,586.22 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL). This firm fixed-price delivery order is non-competitive and utilizes a competitively awarded indefinite delivery contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. As a major...
- The Defense Logistics Agency awarded a $19,487.23 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens with a completion date of September 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and represents a single delivery transaction under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $3,812.90 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on April 22, 2025, with completion scheduled for April 23, 2025. This competitively awarded, firm fixed-price delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under a child delivery order structure, leveraging the company's broader contracting...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEYMMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens valued at $5,564.41. This delivery order, issued under a firm fixed-price contract with no set-aside designation, is due for completion by July 14, 2025. AmerisourceBergen will fulfill this order from its corporate office in Conshohocken, Pennsylvania, where the company maintains operations as a primary pharmaceutical distributor for federal medical procurement needs. This delivery order represents a continuation of AmerisourceBergen's substantial role in supporting the Defense Logistics Agency's pharmaceutical supply chain. The award is issued as a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including those serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 7/11/25 |